1. 1567 Overview of French routine clinical practice for the management of chemotherapy-induced anemia (CIA) with biosimilar epoetin alfa in 1298 patients with solid tumors: A national observational study (The OncoBOS study). (September 2015) Authors: Metges, J.P.; Khobta, N.; Boschetti, G.; Karlin, L.; Toledano, A.; Aubron-olivier, C.; Fernet, D.; Fitoussi, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL. (June 2017) Authors: Gressin, R.; Daguindau, N.; Tempescul, A.; Moreau, A.; Carras, S.; Cartron, G.; Schmitt, A.; Houot, R.; Dartigeas, C.; Pignon, J.; Corm, S.; Bannos, A.; Mounier, C.; Dupuis, J.; Macro, M.; Fleury, J.; Jardin, F.; Karlin, L.; Damaj, G.; Feugier, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY. (June 2017) Authors: Bonnet, C.M.; Lamy, T.; Fruchart, C.; Legouill, S.; Gunzer, K.; Gastinne, T.; Jardin, F.; Karlin, L.; Houot, R.; Dupuis, J.; Tilly, H.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY. (23rd June 2022) Authors: van de Donk, N. W.; Guo, S.; Shi, L.; Lord-Bessen, J.; Tang, D.; Karlin, L.; Weisel, K.; Ramasamy, K.; Abad, P. C.; Amin, A.; Amin, S.; Lonial, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01. (23rd June 2022) Authors: Bobin, A.; Manier, S.; De Keizer, J.; Karlin, L.; Perrot, A.; Hulin, C.; Caillot, D.; Mariette, C.; Lenain, P.; Richez, V.; Tiab, M.; Touzeau, C.; Jaccard, A.; Decaux, O.; Araujo, C.; Belhadj, K.; Benboubker, L.; Déal, C.; Macro, M.; Vincent, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1. (23rd June 2022) Authors: Martínez-López, J.; Moreau, P.; Usmani, S. Z.; Garfall, A.; van de Donk, N. W.; San-Miguel, J. F.; Oriol, A.; Chari, A.; Karlin, L.; Mateos, M.-V.; Popat, R.; Nooka, A. K.; Sidana, S.; Trancucci, D.; Verona, R.; Girgis, S.; Uhlar, C.; Stephenson, T.; Banerjee, A.; Krishnan, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1. (23rd June 2022) Authors: Popat, R.; Moreau, P.; Usmani, S. Z.; Garfall, A.; Mateos, M.-V.; San-Miguel, J. F.; Oriol, A.; Nooka, A. K.; Rosinol, L.; Chari, A.; Karlin, L.; Krishnan, A.; Bahlis, N.; Martin, T.; Besemer, B.; Martínez-López, J.; Delforge, M.; Fastenau, J.; Gries, K. S.; van de Donk, N. W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma. Issue 213 (May 2022) Authors: Charles, S.; Chaudier, A.; Fatrara, T.; Daguenet, E.; Karlin, L.; Montmartin, A.; Boussoualim, K.; Tardy-Poncet, B.; Tardy, B.; Lecompte, T.; Guyotat, D.; Chalayer, E. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Wang, M.; Ramchandren, R.; Chen, R.; Karlin, L.; Chong, G.; Jurczak, W.; Wu, K.; Bishton, M.; Collins, G.; Eliadis, P.; Peyrade, F.; Freise, K.; Sukbuntherng, J.; Lee, Y.; Dobkowska, E.; Fedorov, V.; Neuenburg, J.; Tam, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH-RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-04. (23rd June 2022) Authors: Touzeau, C.; Perrrot, A.; Hulin, C.; Manier, S.; Macro, M.; Chretien, M.-L.; Karlin, L.; Decaux, O.; Jacquet, C.; Tiab, M.; Leleu, X.; Planchce, L.; Avet-Loiseau, H.; Moreau, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗